Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Seminar
March 27, 2006
- Notification on Measures to Promote the Use of Generics Issued
March 27, 2006
- Seminar
March 27, 2006
- Towa, Sawai, and Nichi-iko Will Cooperate to Supply All Specifications
March 27, 2006
- New 3-year Regulatory Reform Plan Coming Soon
March 27, 2006
- Taiyo to Independently Supply All Specifications
March 27, 2006
- REGULATORY NEWS IN BRIEF
March 27, 2006
- JGPMA to Distribute "GE Drug Consultation Card" Free of Charge
March 27, 2006
- Notifications Issued to Explain New Medical Fees
March 27, 2006
- GSK to Begin Clinical Trial of Cervarix in Japan
March 27, 2006
- Rivalry Heats Up as Election Approaches: JMA
March 27, 2006
- Korosho Submits Proposal for "vaccine Industry Vision"
March 27, 2006
- Mr Kodama to Concentrate on JPA
March 27, 2006
- Kyowa Hakko Completes PIII Trials of Parkinson's Treatment KW-6002
March 20, 2006
- JammNet Publishes Generic Market Share Report for 2005
March 20, 2006
- Kyorin Starts PI Study of New Diabetes Treatment in the US
March 20, 2006
- JMA to Hold 27th General Assembly April 5-8 in Osaka
March 20, 2006
- New Drug Applications Declined in 2005: OPIR Survey
March 20, 2006
- Use of Anti-allergy Drugs by GPs Surveyed by JMDC
March 20, 2006
- Slow Clinical Trials Delaying Domestic Launch of New Drugs
March 20, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…